Evaluation of platelet distribution width as a diagnostic and prognostic biomarker in bladder neoplasm.

Aim: To evaluate the role of preoperative platelet distribution width (PDW) as a potential biomarker for distinguishing malignancy and tumor advantage of bladder neoplasm. Methods: The study included 210 subjects with bladder cancer, 76 subjects with urothelial papilloma and 132 healthy control subjects. Preoperative PDW along with other blood indices was evaluated. Results: PDW was higher in urothelial papilloma patients than that in bladder cancer patients (p < 0.001). Bladder cancer patients with advanced-stage disease exhibited lower PDW levels compared with patients with early stage disease. Conclusion: Reduced preoperative PDW level is an indicator of malignancy and advanced bladder cancer stages, suggesting it as a potential biomarker in bladder cancer diagnosis and prognosis.

Future oncology (London, England). 2019 Sep 18 [Epub ahead of print]

Lei Liu, Yajing Zhao, Jianfeng Cui, Shouzhen Chen, Benkang Shi

Department of Urology, Qilu Hospital of Shandong University, Jinan, China., Department of Hematology, Qilu Hospital of Shandong University, Jinan, China.


Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.